JP2001513796A - （ｅ）−４，６−ジクロロ−３−（２−オキソ−１−フェニルピロリジン−３−イリデンメチル）−１ｈ−インドール−２−カルボン酸の結晶性ナトリウム塩水和物 - Google Patents
（ｅ）−４，６−ジクロロ−３−（２−オキソ−１−フェニルピロリジン−３−イリデンメチル）−１ｈ−インドール−２−カルボン酸の結晶性ナトリウム塩水和物Info
- Publication number
- JP2001513796A JP2001513796A JP53813598A JP53813598A JP2001513796A JP 2001513796 A JP2001513796 A JP 2001513796A JP 53813598 A JP53813598 A JP 53813598A JP 53813598 A JP53813598 A JP 53813598A JP 2001513796 A JP2001513796 A JP 2001513796A
- Authority
- JP
- Japan
- Prior art keywords
- sodium salt
- compound
- oxo
- crystalline hydrate
- carboxylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9704498.6A GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
| GB9704498.6 | 1997-03-05 | ||
| PCT/EP1998/001146 WO1998039327A1 (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2001513796A true JP2001513796A (ja) | 2001-09-04 |
Family
ID=10808697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53813598A Pending JP2001513796A (ja) | 1997-03-05 | 1998-03-03 | （ｅ）−４，６−ジクロロ−３−（２−オキソ−１−フェニルピロリジン−３−イリデンメチル）−１ｈ−インドール−２−カルボン酸の結晶性ナトリウム塩水和物 |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0966463A1 (xx) |
| JP (1) | JP2001513796A (xx) |
| KR (1) | KR20000075907A (xx) |
| CN (1) | CN1249750A (xx) |
| AP (1) | AP9901637A0 (xx) |
| AR (1) | AR011178A1 (xx) |
| AU (1) | AU6825198A (xx) |
| BG (1) | BG103779A (xx) |
| BR (1) | BR9808305A (xx) |
| CA (1) | CA2282851A1 (xx) |
| CO (1) | CO4940415A1 (xx) |
| EA (1) | EA199900710A1 (xx) |
| EE (1) | EE9900387A (xx) |
| GB (1) | GB9704498D0 (xx) |
| HR (1) | HRP980114A2 (xx) |
| HU (1) | HUP0002109A2 (xx) |
| ID (1) | ID24207A (xx) |
| IL (1) | IL131489A0 (xx) |
| IS (1) | IS5166A (xx) |
| NO (1) | NO994303L (xx) |
| NZ (1) | NZ337315A (xx) |
| OA (1) | OA11154A (xx) |
| PE (1) | PE51399A1 (xx) |
| PL (1) | PL335652A1 (xx) |
| SK (1) | SK119699A3 (xx) |
| TR (1) | TR199902117T2 (xx) |
| WO (1) | WO1998039327A1 (xx) |
| YU (1) | YU43499A (xx) |
| ZA (1) | ZA981791B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704499D0 (en) * | 1997-03-05 | 1997-04-23 | Glaxo Wellcome Spa | Method of manufacture |
| GB9825988D0 (en) | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
| GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| KR102609676B1 (ko) | 2017-06-12 | 2023-12-05 | 글리테크 엘엘씨. | Nmda 길항제 및 d2/5ht2a 또는 선택적 5ht2a 길항제를 이용한 우울증의 치료 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321221D0 (en) * | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
-
1997
- 1997-03-05 GB GBGB9704498.6A patent/GB9704498D0/en active Pending
-
1998
- 1998-03-03 KR KR1019997007987A patent/KR20000075907A/ko not_active Application Discontinuation
- 1998-03-03 ID IDW990976A patent/ID24207A/id unknown
- 1998-03-03 IL IL13148998A patent/IL131489A0/xx unknown
- 1998-03-03 SK SK1196-99A patent/SK119699A3/sk unknown
- 1998-03-03 BR BR9808305-8A patent/BR9808305A/pt not_active Application Discontinuation
- 1998-03-03 AR ARP980100948A patent/AR011178A1/es unknown
- 1998-03-03 CA CA002282851A patent/CA2282851A1/en not_active Abandoned
- 1998-03-03 PE PE1998000149A patent/PE51399A1/es not_active Application Discontinuation
- 1998-03-03 EP EP98913613A patent/EP0966463A1/en not_active Withdrawn
- 1998-03-03 WO PCT/EP1998/001146 patent/WO1998039327A1/en not_active Application Discontinuation
- 1998-03-03 PL PL98335652A patent/PL335652A1/xx unknown
- 1998-03-03 CN CN98803053A patent/CN1249750A/zh active Pending
- 1998-03-03 EE EEP199900387A patent/EE9900387A/xx unknown
- 1998-03-03 EA EA199900710A patent/EA199900710A1/ru unknown
- 1998-03-03 CO CO98011404A patent/CO4940415A1/es unknown
- 1998-03-03 ZA ZA9801791A patent/ZA981791B/xx unknown
- 1998-03-03 YU YU43499A patent/YU43499A/sh unknown
- 1998-03-03 AU AU68251/98A patent/AU6825198A/en not_active Abandoned
- 1998-03-03 AP APAP/P/1999/001637A patent/AP9901637A0/en unknown
- 1998-03-03 TR TR1999/02117T patent/TR199902117T2/xx unknown
- 1998-03-03 HU HU0002109A patent/HUP0002109A2/hu unknown
- 1998-03-03 NZ NZ337315A patent/NZ337315A/en unknown
- 1998-03-03 JP JP53813598A patent/JP2001513796A/ja active Pending
- 1998-03-04 HR HR9704498.6A patent/HRP980114A2/hr not_active Application Discontinuation
-
1999
- 1999-08-27 IS IS5166A patent/IS5166A/is unknown
- 1999-09-02 OA OA9900201A patent/OA11154A/fr unknown
- 1999-09-03 NO NO994303A patent/NO994303L/no not_active Application Discontinuation
- 1999-10-04 BG BG103779A patent/BG103779A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6825198A (en) | 1998-09-22 |
| CA2282851A1 (en) | 1998-09-11 |
| IL131489A0 (en) | 2001-01-28 |
| IS5166A (is) | 1999-08-27 |
| SK119699A3 (en) | 2000-05-16 |
| CO4940415A1 (es) | 2000-07-24 |
| KR20000075907A (ko) | 2000-12-26 |
| OA11154A (en) | 2003-04-16 |
| HUP0002109A2 (hu) | 2001-04-28 |
| NO994303L (no) | 1999-11-03 |
| BR9808305A (pt) | 2000-05-16 |
| HRP980114A2 (en) | 1998-12-31 |
| EP0966463A1 (en) | 1999-12-29 |
| NZ337315A (en) | 2001-02-23 |
| EA199900710A1 (ru) | 2000-04-24 |
| GB9704498D0 (en) | 1997-04-23 |
| EE9900387A (et) | 2000-04-17 |
| AP9901637A0 (en) | 1999-09-30 |
| ZA981791B (en) | 1999-09-03 |
| YU43499A (sh) | 2000-12-28 |
| ID24207A (id) | 2000-07-13 |
| CN1249750A (zh) | 2000-04-05 |
| NO994303D0 (no) | 1999-09-03 |
| PE51399A1 (es) | 1999-06-07 |
| AR011178A1 (es) | 2000-08-02 |
| WO1998039327A1 (en) | 1998-09-11 |
| BG103779A (en) | 2000-06-30 |
| TR199902117T2 (xx) | 2000-03-21 |
| PL335652A1 (en) | 2000-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4490911B2 (ja) | β−２アゴニストとしてのインドール誘導体 | |
| TWI519532B (zh) | （Ｒ）－７－氯－Ｎ－（啶－３－基）苯並［b］噻吩－２－羧醯胺鹽酸鹽單水合物之結晶形體 | |
| JPH07505407A (ja) | インドール誘導体 | |
| JP2002501529A (ja) | Ｓ−オメプラゾールの新規な形態 | |
| JP2001519346A (ja) | 抗真菌性結晶性多形物 | |
| EP2631234A1 (en) | Solid forms of dabigatran etexilate mesylate and processes for their preparation | |
| JPH09503770A (ja) | Ｎｍｄａアンタゴニストとしてのインドール誘導体 | |
| JP2000505450A (ja) | キノロン類およびこれらの治療的使用 | |
| JPH02178281A (ja) | β―ラクタム抗生物質の水和物 | |
| JP2001513796A (ja) | （ｅ）−４，６−ジクロロ−３−（２−オキソ−１−フェニルピロリジン−３−イリデンメチル）−１ｈ−インドール−２−カルボン酸の結晶性ナトリウム塩水和物 | |
| JP2002532470A (ja) | パロキセチンマレイン酸塩の製法 | |
| JP2001518901A (ja) | キノリン−２−カルボン酸誘導体およびその興奮性アミノ酸拮抗薬としての使用 | |
| JP4311901B2 (ja) | 複素環誘導体 | |
| CN110234631B (zh) | 用于治疗高血压和/或纤维化的组合物 | |
| JP2023506025A (ja) | レンボレキサントの固体形態 | |
| JP2002528541A (ja) | Ｔｎｆおよびｐｄｅ−ｉｖ阻害活性を有する複素環式化合物のｎ−オキシド | |
| JP2791069B2 (ja) | シクロオクタン神経保護剤 | |
| WO2002008229A1 (fr) | DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO [4,5-β] INDOLE-1-CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE | |
| CZ314799A3 (cs) | Krystalická hydratovaná sodná sůl kyseliny (E)-4,6-dichlor-3-(2-oxo-l-fenylpyrrolidin-3- ylidenmethyl)-lH-indol-2-karboxylové | |
| JPH10503532A (ja) | レソピトロン二塩酸塩の新規多形およびその水和形その製造方法およびそれを含有する組成物 | |
| KR20030069228A (ko) | 나트륨-수소 교환물질 1형 억제제의 에탄올레이트 |